Nektar Therapeutics | NKTR - Assets


Nektar Therapeutics reported $763.27M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agios Pharmaceuticals USD 1.11B 76.57M Jun/2026
ALKERMES USD 4.39B 135.05M Jun/2026
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Amgen USD 95.64B 3.14B Jun/2026
Baxter International USD 19.79B 55M Jun/2026
BioCryst Pharmaceuticals USD 557.85M 92.8M Jun/2026
Biogen USD 32.09B 2.6B Jun/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Cara Therapeutics USD 25.82M 6.26M Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Dr.Reddys Laboratories INR 575.31B 5.93B Jun/2026
Eisai JPY 1.56T 108.98B Jun/2026
Eli Lilly USD 142.28B 25.71B Jun/2026
Exelixis USD 2.49B 99.36M Jun/2026
Gilead Sciences USD 49.36B 6.92B Jun/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
Grifols EUR 23.15B 142.7M Dec/2025
Halozyme Therapeutics USD 2.58B 95.31M Jun/2026
Incyte USD 7.87B 533.53M Jun/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
Ironwood Pharmaceuticals USD 434.57M 37.66M Mar/2026
Karyopharm Therapeutics USD 131.42M 23M Mar/2026
MacroGenics USD 345.41M 127.54M Jun/2026
Merck USD 129.8B 1.12B Jun/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Neurocrine Biosciences USD 5.36B 452.9M Jun/2026
Novartis USD 122.03B 3.5B Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sarepta Therapeutics USD 3.19B 9.58M Jun/2026
Takeda JPY 15.66T 210.16B Jun/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
Xencor USD 724.96M 11.89M Jun/2026